SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-108544
Filing Date
2024-04-24
Accepted
2024-04-24 08:01:10
Documents
54
Period of Report
2024-04-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812370d8k.htm   iXBRL 8-K 38575
2 EX-99.1 d812370dex991.htm EX-99.1 48781
3 EX-99.2 d812370dex992.htm EX-99.2 51269
7 GRAPHIC g812370ex99_2p10g1.jpg GRAPHIC 275055
8 GRAPHIC g812370ex99_2p11g1.jpg GRAPHIC 242686
9 GRAPHIC g812370ex99_2p12g1.jpg GRAPHIC 253553
10 GRAPHIC g812370ex99_2p13g1.jpg GRAPHIC 481010
11 GRAPHIC g812370ex99_2p14g1.jpg GRAPHIC 207806
12 GRAPHIC g812370ex99_2p15g1.jpg GRAPHIC 246125
13 GRAPHIC g812370ex99_2p16g1.jpg GRAPHIC 248875
14 GRAPHIC g812370ex99_2p17g1.jpg GRAPHIC 249121
15 GRAPHIC g812370ex99_2p18g1.jpg GRAPHIC 230865
16 GRAPHIC g812370ex99_2p19g1.jpg GRAPHIC 234347
17 GRAPHIC g812370ex99_2p1g1.jpg GRAPHIC 276326
18 GRAPHIC g812370ex99_2p20g1.jpg GRAPHIC 298499
19 GRAPHIC g812370ex99_2p21g1.jpg GRAPHIC 239285
20 GRAPHIC g812370ex99_2p22g1.jpg GRAPHIC 397578
21 GRAPHIC g812370ex99_2p23g1.jpg GRAPHIC 344172
22 GRAPHIC g812370ex99_2p24g1.jpg GRAPHIC 279729
23 GRAPHIC g812370ex99_2p25g1.jpg GRAPHIC 60679
24 GRAPHIC g812370ex99_2p26g1.jpg GRAPHIC 257743
25 GRAPHIC g812370ex99_2p27g1.jpg GRAPHIC 304007
26 GRAPHIC g812370ex99_2p28g1.jpg GRAPHIC 384318
27 GRAPHIC g812370ex99_2p29g1.jpg GRAPHIC 252544
28 GRAPHIC g812370ex99_2p2g1.jpg GRAPHIC 479448
29 GRAPHIC g812370ex99_2p30g1.jpg GRAPHIC 330191
30 GRAPHIC g812370ex99_2p31g1.jpg GRAPHIC 326985
31 GRAPHIC g812370ex99_2p32g1.jpg GRAPHIC 237142
32 GRAPHIC g812370ex99_2p33g1.jpg GRAPHIC 325996
33 GRAPHIC g812370ex99_2p34g1.jpg GRAPHIC 254631
34 GRAPHIC g812370ex99_2p35g1.jpg GRAPHIC 244314
35 GRAPHIC g812370ex99_2p36g1.jpg GRAPHIC 253832
36 GRAPHIC g812370ex99_2p37g1.jpg GRAPHIC 303458
37 GRAPHIC g812370ex99_2p38g1.jpg GRAPHIC 326330
38 GRAPHIC g812370ex99_2p3g1.jpg GRAPHIC 365752
39 GRAPHIC g812370ex99_2p4g1.jpg GRAPHIC 224670
40 GRAPHIC g812370ex99_2p5g1.jpg GRAPHIC 266131
41 GRAPHIC g812370ex99_2p6g1.jpg GRAPHIC 215658
42 GRAPHIC g812370ex99_2p7g1.jpg GRAPHIC 392814
43 GRAPHIC g812370ex99_2p8g1.jpg GRAPHIC 269505
44 GRAPHIC g812370ex99_2p9g1.jpg GRAPHIC 375607
45 GRAPHIC g812370g0424005234612.jpg GRAPHIC 3003
  Complete submission text file 0001193125-24-108544.txt   15398503

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dawn-20240423.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20240423_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20240423_pre.xml EX-101.PRE 11265
57 EXTRACTED XBRL INSTANCE DOCUMENT d812370d8k_htm.xml XML 3654
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 24866766
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)